Skip to main content

Table 1 Association between haplogroup status and invasive serous ovarian cancer risk

From: Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk

Euroeapn

Haplogroup-tagging SNPs

Allele

Case/control proportions

OR (95% CI)

P

Haplogroup

H

rs2015062

C

0.53 / 0.50

1.10 (0.82-1.51)

0.54

U

rs28358571, rs2853499, rs2854122

T, A, C

0.19 / 0.20

0.94 (0.64-1.39)

0.77

J

rs2015062, rs2854122, rs28359178

T, C, A

0.10 / 0.09

1.16 (0.70-1.93)

0.61

K

rs28358571

C

0.09 / 0.09

0.98 (0.59-1.65)

1.00

V

rs2015062, rs2853495, rs2853506

T, G, A

0.05 / 0.07

0.63 (0.32-1.23)

0.18

W

rs2854122, rs41535848, rs28357684

T, A, G

0.02 / 0.02

1.12 (0.41-3.49)

0.79

X

rs2853517, rs2854122, rs28357684

G, T, G

0.02 / 0.03

0.67 (0.23-1.94)

0.59

I

rs8896, rs41347846, mt14182

G, C, T

0.00 / 0.00

-

1.00

T

rs3088053, rs3926883

A, C

NA / NA

-

1.00

  1. Table is ordered by haplogroup frequency in cases. Haplogroup tagging MT-SNPs and allele are as reported by Saxena et al., 2006. OR; odd ratio, is calculated for a total of 671 samples (317 cases and 354 controls) assigned a unique haplogroup. P is the Fischer’s exact P-value for testing haplogroup frequency and case status. Haplogroup T could not be assigned because rs3926883 was not genotyped. This SNP did not pass quality control. NA is not available.